Professor Steven Myint (Dutton's 1975) to support health of Greater Manchester citizens through research and innovation

Professor Steven Myint (Dutton's 1975) has been appointed to the board of Health Innovation Manchester.

Health Innovation Manchester works with innovators to discover, develop and deploy new solutions that improve the health and wellbeing of Greater Manchester’s 2.8m citizens.

Professor Steven Myint is a former NHS consultant, university Professor and Faculty Dean with international business experience across public, private and NGO sectors. He has considerable entrepreneurial experience and has been the founder of several companies across biotech, medtech, diagnostics, AI and corporate culture.

Steven has been a board level executive in biotech and pharmaceutical multinational companies, including Medical Director for Global Research and Development at GSK Global, and Senior Vice-President for R&D and Chief Medical Officer at BTG International. He is currently the Chairman of Inex Private Ltd, non-executive director of Aplagon Oy and Medisapiens Oy, and Co-chairman of the External Advisory Network for the Royal College of Surgeons of England.

Commenting on his appointment, Steven said: “I look forward to bringing my experience across multiple sectors to guide strategy, growth and innovation at Health Innovation Manchester. The Greater Manchester health and care system is already demonstrating the ability to forge strong and sustainable partnerships, and I welcome the opportunity to support the board in achieving Health Innovation Manchester’s vision to become a recognised international leader in accelerating innovation.”